Eikon Therapeutics
company
Funding Round
Series B
Money Raised
$ 518M
Propotion
-
Post Valuation
-
Current Round Investors
| Investor Name | Invest Money | Lead Investor | Propotion | |
|---|---|---|---|---|
| Horizons Ventures | - | - | - | Detail |
| UC Investments | - | - | - | Detail |
| The Column Group | - | - | - | Detail |
| T. Rowe Price | - | - | - | Detail |
| StepStone Group | - | - | - | Detail |
| Soros Capital Management | - | - | - | Detail |
| Schroders Capital | - | - | - | Detail |
| Lux Capital | - | - | - | Detail |
| Innovation Endeavors | - | - | - | Detail |
| Abu Dhabi Investment Authority | - | - | - | Detail |
| Hartford HealthCare Endowment | - | - | - | Detail |
| Harel Insurance Investments and Financial Services | - | - | - | Detail |
| General Catalyst | - | - | - | Detail |
| Foresite Capital | - | - | - | Detail |
| EcoR1 Capital | - | - | - | Detail |
| E15 VC | - | - | - | Detail |
| Canada Pension Plan Investment Board | - | - | - | Detail |
| AME Cloud Ventures | - | - | - | Detail |
Historical Financing
| Announced Date | Round | Money Raised | Investors | |
|---|---|---|---|---|
| Jan 1, 2019 | Seed | 0 | Lux Capital | Detail |
| May 5, 2021 | Series A | $ 148M | Foresite Capital,Innovation Endeavors,etc. | Detail |
